Baxion
Screening
Tags
Alerts
Theme
Protagonist Therapeutics, Inc.
PTGX
·
NASDAQ
·
$99.98
Share Price as of 11/2
·
$6B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/05/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
02/25/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/06/25
Disclosures
Filter
8-K
Current report
08/05/26
8-K
Current report
06/18/26
8-K
Results of Operations
05/05/26
8-K
Results of Operations
02/25/26
8-K
Regulation FD Disclosure
01/12/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
Proxies
Filter
DEF 14A
Definitive proxy
04/28/26
DEFA14A
Additional proxy materials
04/28/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/29/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
Form 4
Insider transaction
10/02/26
144
Proposed sale of securities
09/30/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
09/08/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Other
Filter
ARS
Annual report to shareholders
04/28/26
ARS
Annual report to shareholders
04/29/25
ARS
Annual report to shareholders
04/26/24
ARS
Annual report to shareholders
04/12/23
EFFECT
Request for effectiveness
08/16/22
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/05/26
8-K
Current report
08/05/26
S-8
Registration of securities for employees
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
S-8 POS
Post-effective amendment (S-8)
08/05/26
Ownership
Filter
Form 4
Insider transaction
10/02/26
144
Proposed sale of securities
09/30/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
09/08/26
SC 13G/A
Beneficial ownership (amended)
08/13/26